Skip to main content
OpenTrials

Clinical trial condition

alpha 1-Antitrypsin Deficiency

Explore clinical trials studying alpha 1-Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

100 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

alpha 1-Antitrypsin Deficiency trial results

Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

NCT00295061

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

NCT00301366

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

NCT01213043

Conditions
Alpha 1-antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Temple University Hosptial/Temple Lung Center Philadelphia, Pennsylvania, United States
  • Medical University of South Carolina, Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

NCT01419158

Conditions
Alpha-1 Antitrypsin Deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida (Gainesville) Gainesville, Florida, United States
  • University of Florida (Jacksonville) Jacksonville, Florida, United States
View all 19 locations
View Trial Details
Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
  • The University of Texas Health Center at Tyler Tyler, Texas, United States
View Trial Details
Terminated

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University Hospital (UZ) Leuven Leuven, Belgium
  • Tays Central Hospital Tampere, Finland
  • Beaumont Hospital Dublin, Ireland
  • Leiden University Medical Center (LUMC) Leiden, ZA, Netherlands
View Trial Details

Related conditions